These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 7539512
1. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40. Crawford DH, Thomas JA, Gregory CD, Catovsky D, Chaggar K. Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512 [Abstract] [Full Text] [Related]
2. Infection of leukaemic B lymphocytes by Epstein Barr virus. Doyle MG, Catovsky D, Crawford DH. Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253 [Abstract] [Full Text] [Related]
3. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Crawford DH, Catovsky D. Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945 [Abstract] [Full Text] [Related]
4. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. Wendel-Hansen V, Sällström J, De Campos-Lima PO, Kjellström G, Sandlund A, Siegbahn A, Carlsson M, Nilsson K, Rosén A. Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151 [Abstract] [Full Text] [Related]
5. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E. J Immunol Methods; 2012 Nov 30; 385(1-2):60-70. PubMed ID: 22921685 [Abstract] [Full Text] [Related]
6. Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Walls EV, Doyle MG, Patel KK, Allday MJ, Catovsky D, Crawford DH. Int J Cancer; 1989 Nov 15; 44(5):846-53. PubMed ID: 2555307 [Abstract] [Full Text] [Related]
7. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Kis LL, Takahara M, Nagy N, Klein G, Klein E. Immunol Lett; 2006 Apr 15; 104(1-2):83-8. PubMed ID: 16386314 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle. Teramoto N, Gogolák P, Nagy N, Maeda A, Kvarnung K, Björkholm T, Klein E. J Hum Virol; 2000 Apr 15; 3(3):125-36. PubMed ID: 10881992 [Abstract] [Full Text] [Related]
9. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells. Fluckiger AC, Brière F, Zurawski G, Bridon JM, Banchereau J. Immunology; 1994 Nov 15; 83(3):397-403. PubMed ID: 7530690 [Abstract] [Full Text] [Related]
10. [Studies on transforming functions of Epstein-Barr virus-specific proteins]. Kinoshita T. Hokkaido Igaku Zasshi; 1990 Jul 15; 65(4):362-75. PubMed ID: 2172130 [Abstract] [Full Text] [Related]
11. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Arvanitakis L, Yaseen N, Sharma S. J Immunol; 1995 Aug 01; 155(3):1047-56. PubMed ID: 7636179 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ, Crawford DH, Thomas JA. J Gen Virol; 1993 Mar 01; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. J Virol; 1990 May 01; 64(5):2309-18. PubMed ID: 2157887 [Abstract] [Full Text] [Related]
14. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB. Nature; 1991 Feb 14; 349(6310):612-4. PubMed ID: 1705663 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K, Suzumiya J, Tasiro K, Mukai Y, Tanaka T, Kato A, Kikuchi M. Am J Hematol; 1996 May 14; 52(1):21-8. PubMed ID: 8638607 [Abstract] [Full Text] [Related]
16. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W. J Med Virol; 2001 Sep 14; 65(1):114-20. PubMed ID: 11505452 [Abstract] [Full Text] [Related]
17. EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells. Bandobashi K, Liu A, Nagy N, Kis LL, Nishikawa J, Björkholm M, Klein G, Klein E. Virus Genes; 2005 May 14; 30(3):323-30. PubMed ID: 15830149 [Abstract] [Full Text] [Related]
18. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A, Pfaff P, Lange W, Finke J. Cytokines Mol Ther; 1996 Mar 14; 2(1):21-8. PubMed ID: 9384686 [Abstract] [Full Text] [Related]
19. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG. Eur J Immunol; 1990 Oct 14; 20(10):2293-9. PubMed ID: 2173662 [Abstract] [Full Text] [Related]
20. Cytokines and Epstein Barr virus (EBV) genes expression in blood chronic lymphocytic leukaemia (CLL) cells and their immortalised CLL cell lines. Laytragoon-Lewin N, Chen F, Castro J, Avila-Carino J, Lewin F. Anticancer Res; 2003 Oct 14; 23(5A):4017-22. PubMed ID: 14666712 [Abstract] [Full Text] [Related] Page: [Next] [New Search]